Powerful Medical at ACC 2025: Advancing AI in Cardiovascular Care
We are excited to announce that Powerful Medical will be attending the American College of Cardiology (ACC) 2025 Conference, taking place from March 29th – 31st, 2025, in Chicago, IL, USA. Once again, we have a strong presence at the conference, with multiple papers being presented, underscoring our continued leadership in AI-driven cardiovascular diagnostics.
Optimizing ACS Management: Quality Metrics, Enhanced Digitization & Patient Outcome Feedback in PMcardio’s Latest Update
Our new major update includes a dashboard and insights, real-time outcome feedback, enhanced digitization, and faster explainability. With AI-powered ECG interpretation and advanced analytics, healthcare institutions gain actionable data to optimize clinical workflows, improve patient outcomes, and drive efficiency.
ECGxplain™: The Explainability Feature in PMcardio -With Human-Centered Design in Mind
In high-stakes emergency and cath lab settings, every second counts when diagnosing acute myocardial infarctions. PMcardio’s Explainability feature brings unmatched transparency to AI-powered ECG analysis, empowering clinicians with clear, trustworthy insights for faster, more confident decision-making.
2024 Highlights – A Year of Unprecedented Growth and Innovation
From securing pivotal funding and attaining top-tier certifications to expanding our global reach and leading cutting-edge research, this year has been marked by remarkable progress and validation.
Advanced STEMI Detection and Improved Cath Lab Activation through ECG Transmission and Notifications
By utilizing advanced AI technology, PMcardio simplifies complex diagnostics, delivering real-time insights to support clinical decisions. Its Notification Functionality enhances communication and accelerates care delivery with manual and automated alerts, ensuring timely interventions.
Announcing the AI-ECG TIMI Study: A Multi-Center Validation
We are thrilled to announce the launch of the AI-ECG TIMI Study, a novel, international, multi-center observational study aimed at validating the use of AI to improve the detection and management of acute coronary syndromes (ACS).
PMcardio Expands AI-Powered ECG Solution to Telemedicine for Pharmacy and Primary Care-Based Patient Screening
PMcardio, an AI-driven, CE-certified class (II)b medical device developed by Powerful Medical, is now supporting telemedicine workflows to enhance ECG analysis and diagnosis for patients outside traditional hospital settings.
PMcardio Steals the Show at AHA 2024, Demonstrating High Accuracy with 5 Clinical Validation Studies
The American Heart Association (AHA) conference is one of the most anticipated cardiology events in the world, bringing together 15,000 to 18,000 attendees each year—from trailblazing researchers to frontline clinicians and innovators shaping the future of heart health.
Powerful Medical Wins Best Science Pitch and Overall Winner at AHA Health Tech Competition 2024
Powerful Medical has been named the Best Science Pitch and Overall Winner at the prestigious American Heart Association (AHA) Health Tech Competition during the AHA 2024 Scientific Sessions held in Chicago, Illinois.
Powerful Medical at AHA 2024: Leading the Way in AI-driven Cardiac Care
We are thrilled to announce that Powerful Medical will be attending the American Heart Association (AHA) 2024 Conference, taking place from November 16th – 18th, 2024, at the McCormick Place Convention Center in Chicago, IL, USA.
